000 | 01493 a2200445 4500 | ||
---|---|---|---|
005 | 20250513193504.0 | ||
264 | 0 | _c19991122 | |
008 | 199911s 0 0 eng d | ||
022 | _a0006-4971 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNoris, M | |
245 | 0 | 0 |
_aUremic bleeding: closing the circle after 30 years of controversies? _h[electronic resource] |
260 |
_bBlood _cOct 1999 |
||
300 |
_a2569-74 p. _bdigital |
||
500 | _aPublication Type: Historical Article; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAnemia _xdrug therapy |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArginine _xmetabolism |
650 | 0 | 4 | _aBleeding Time |
650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aErythropoietin _xtherapeutic use |
650 | 0 | 4 |
_aGuanidines _xblood |
650 | 0 | 4 |
_aHemorrhage _xetiology |
650 | 0 | 4 | _aHistory, 18th Century |
650 | 0 | 4 | _aHistory, 20th Century |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 |
_aNitroarginine _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSuccinates _xblood |
650 | 0 | 4 |
_aUremia _xblood |
650 | 0 | 4 |
_aomega-N-Methylarginine _xpharmacology |
700 | 1 | _aRemuzzi, G | |
773 | 0 |
_tBlood _gvol. 94 _gno. 8 _gp. 2569-74 |
|
999 |
_c10472911 _d10472911 |